EQ
Price
$0.47
Change
-$0.00 (-0.00%)
Updated
Apr 4 closing price
Capitalization
17.16M
33 days until earnings call
PRQR
Price
$1.18
Change
-$0.09 (-7.09%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
124.15M
33 days until earnings call
Ad is loading...

EQ vs PRQR

Header iconEQ vs PRQR Comparison
Open Charts EQ vs PRQRBanner chart's image
Equillium
Price$0.47
Change-$0.00 (-0.00%)
Volume$171.28K
Capitalization17.16M
ProQR Therapeutics
Price$1.18
Change-$0.09 (-7.09%)
Volume$9.6K
Capitalization124.15M
EQ vs PRQR Comparison Chart
Loading...
EQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EQ vs. PRQR commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQ is a Hold and PRQR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (EQ: $0.47 vs. PRQR: $1.27)
Brand notoriety: EQ and PRQR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EQ: 5% vs. PRQR: 83%
Market capitalization -- EQ: $17.16M vs. PRQR: $124.15M
EQ [@Biotechnology] is valued at $17.16M. PRQR’s [@Biotechnology] market capitalization is $124.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EQ’s FA Score shows that 1 FA rating(s) are green whilePRQR’s FA Score has 1 green FA rating(s).

  • EQ’s FA Score: 1 green, 4 red.
  • PRQR’s FA Score: 1 green, 4 red.
According to our system of comparison, both EQ and PRQR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EQ’s TA Score shows that 4 TA indicator(s) are bullish while PRQR’s TA Score has 3 bullish TA indicator(s).

  • EQ’s TA Score: 4 bullish, 5 bearish.
  • PRQR’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, EQ is a better buy in the short-term than PRQR.

Price Growth

EQ (@Biotechnology) experienced а -3.89% price change this week, while PRQR (@Biotechnology) price change was -11.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.73%. For the same industry, the average monthly price growth was -16.65%, and the average quarterly price growth was -18.36%.

Reported Earning Dates

EQ is expected to report earnings on May 08, 2025.

PRQR is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-10.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRQR($124M) has a higher market cap than EQ($17.2M). EQ YTD gains are higher at: -37.316 vs. PRQR (-52.075). EQ has higher annual earnings (EBITDA): -4.46M vs. PRQR (-24.12M). PRQR has more cash in the bank: 149M vs. EQ (25.9M). EQ has less debt than PRQR: EQ (497K) vs PRQR (17.2M). EQ has higher revenues than PRQR: EQ (45.9M) vs PRQR (18.9M).
EQPRQREQ / PRQR
Capitalization17.2M124M14%
EBITDA-4.46M-24.12M19%
Gain YTD-37.316-52.07572%
P/E RatioN/AN/A-
Revenue45.9M18.9M243%
Total Cash25.9M149M17%
Total Debt497K17.2M3%
FUNDAMENTALS RATINGS
EQ vs PRQR: Fundamental Ratings
EQ
PRQR
OUTLOOK RATING
1..100
5176
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
29
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9497
PRICE GROWTH RATING
1..100
9493
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EQ's Valuation (20) in the Biotechnology industry is in the same range as PRQR (29). This means that EQ’s stock grew similarly to PRQR’s over the last 12 months.

EQ's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PRQR (100). This means that EQ’s stock grew similarly to PRQR’s over the last 12 months.

EQ's SMR Rating (94) in the Biotechnology industry is in the same range as PRQR (97). This means that EQ’s stock grew similarly to PRQR’s over the last 12 months.

PRQR's Price Growth Rating (93) in the Biotechnology industry is in the same range as EQ (94). This means that PRQR’s stock grew similarly to EQ’s over the last 12 months.

PRQR's P/E Growth Rating (100) in the Biotechnology industry is in the same range as EQ (100). This means that PRQR’s stock grew similarly to EQ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EQPRQR
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 17 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
EQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRIB0.57-0.02
-2.57%
Trinity Biotech plc
IRT20.55-0.83
-3.88%
Independence Realty Trust
SSTI16.24-0.69
-4.08%
SoundThinking
CDW151.57-12.90
-7.84%
CDW Corp
MBUU28.71-2.90
-9.17%
Malibu Boats